Health Care/Hospital

WuXi Biologics Congratulates Immutep on Positive Interim Data for IMP-321

SHANGHAI, Feb. 23, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, congratulates its strategic partner Immutep, a biotechnology comp...

2020-02-24 08:00 6131

Enterprises Resume Work and Production in Xi'an, China amid Novel Coronavirus Outbreak

XI'AN, China, Feb. 21, 2020 /PRNewswire/ -- As China continues to tackle the n ovel coronavirus outbreak, its industries have started to return to work in an orderly manner.Xi'an, one of the national central cities and an important scientific research, educational and industrial base inChina, has ...

2020-02-21 19:36 2090

Yum China Stands with Communities to Fight Coronavirus

SHANGHAI, Feb. 20, 2020 /PRNewswire/ -- Yum China Holdings, Inc. (the "Company" or "Yum China") (NYSE: YUMC) today announced that it has been actively mobilizing resources in a multi-pronged response to the outbreak of novel coronavirus (COVID-19). As part of its efforts, the Company immediately ...

2020-02-21 09:54 12141

VolitionRx Limited Announces Full Fiscal Year 2019 Financial Results and Business Update

AUSTIN, Texas, Feb. 20, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced financial results and a business update for the full fiscal year endedDecember 31, 2019. Volition management will host a conference call tomorrow,February 21, at 8:30 a.m. U.S. Easte...

2020-02-21 05:10 10105

StoneWise AI-driven Drug Discovery Platform: Investigation and Repurpose of Nucleoside-based RNA Polymerase Inhibitors and Their Potential Use in COVID-19 Infection Treatment

BEIJING, Feb. 20, 2020 /PRNewswire/ -- In a campaign to screen drugs for the treatment of COVID-19, the disease caused by SARS-CoV-2, StoneWise, a company specialized in applying artificial intelligence to innovative drug design solutions for innovative drug R&D enterprises and institutions, has ...

2020-02-20 20:04 1408

111 to Announce Fourth Quarter and Fiscal Year 2019 Unaudited Financial Results on March 12, 2020

SHANGHAI, Feb. 20, 2020 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform inChina , today announced that it will report its unaudited financial results for the fourth quarter and fiscal year 2019 endedDecember 31, 2019, bef...

2020-02-20 17:15 10321

111 Partners with Financial Institutions in Battle Against Coronavirus

SHANGHAI, Feb. 20, 2020 /PRNewswire/ -- 111, Inc. (NASDAQ: YI, "111" or the "Company") has announced that it will leverage its knowhow and technology in the battle against the novel coronavirus (COVID-19) public health crisis, through partnerships with some ofChina's leading financial institution...

2020-02-20 17:00 5339

Ten billion investment to build Chengdu medical city to create a new highland for the international health industry

CHENGDU, China, Feb. 20, 2020 /PRNewswire/ -- In 2019, with the continuous advancement of "three medical integration", Chengdu Medical City's three medical innovation center, as "Western China Biomedical Innovation Center", submitted a satisfactory answer sheet: 58 new contracted projects (47 thr...

2020-02-20 16:04 767

Industrial enterprises in Weifang, Shandong resume work and production while fighting epidemic

WEIFANG, China, Feb. 20, 2020 /PRNewswire/ -- In order to respond to the epidemic of novel coronavirus pneumonia (NCP), the government ofShandong Province has issued a notice that requires enterprises that are key to national economy and people's livelihoods to immediately resume work and product...

2020-02-20 13:37 1283

VolitionRx Limited Schedules Full Year 2019 Earnings Conference Call and Business Update

AUSTIN, Texas, Feb. 18, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced it will host a conference call onFriday, February 21 at 8:30 a.m. Eastern time to discuss its financial and operating results for the fourth quarter and full year 2019, in conjunctio...

2020-02-19 05:10 10244

Mankind should share sorrows when facing COVID-19

BEIJING, Feb. 18, 2020 /PRNewswire/ -- A news report by China.org.cn on some Western media's virus-related xenophobic comments againstChina:   The 2019 novel coronavirus disease (COVID-19) is currently under the spotlight around the world, with cases having been confirmed in ove...

2020-02-19 00:13 1299

Transcenta Achieves Major Milestone in Continuous Perfusion Cell Culture Platform to Provide Industry Leading Productivity and Speed to Manufacturing

SUZHOU and HANGZHOU, China, Feb. 18, 2020 /PRNewswire/ -- Transcenta, a global biotherapeutics company that fully integrates antibody-based biotherapeutics discovery, R&D, regulatory affairs and manufacturing, today announced it has achieved a major milestone in its continuous perfusion cell cult...

2020-02-19 00:00 755

Henlius successfully held its fourth Scientific Advisory Board (SAB) meeting

SHANGHAI, Feb. 18, 2020 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK, Henlius), a global biologics company specialized in the discovery and development of high-quality and affordable antibodies for the treatment of patients with cancer and autoimmune diseases, recently held its fourth ...

2020-02-18 21:59 6507

Volition Unveils Its Epigenetic Toolbox

AUSTIN, Texas, Feb. 18, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that research on its Nu.Q(TM) Capture program has led to the development of a suite of novel epigenetic tools building on the breakthroughs announced last month on its assay platform...

2020-02-18 21:30 8611

Ally Bridge Group Leads US$70 million Investments in Two Israeli Life Science Companies over the Last 2 Months

TEL AVIV, Israel, HONG KONG and NEW YORK, Feb. 18, 2020 /PRNewswire/ — Ally Bridge Group ("ABG"), a leading global life science investment group, has announced that it recently ledUS$70 million investments in two Israeli life science companies over the last 2 months. Each of the two companies is ...

2020-02-18 21:30 1798

Model indicates current novel coronavirus infections in China declining

SUZHOU, China, Feb. 15, 2020 /PRNewswire/ -- A mathematical model set up by an ad-hoc group of scientists indicates the number of currently infected novel coronavirus cases inChina are on the decline as of February 12.  Currently infected cases are those confirmed to be ill with the virus who hav...

2020-02-15 21:43 1553

Informa Markets Malaysia Hosts Business Community To Provide Clarity On Coronavirus Situation

KUALA LUMPUR, Malaysia, Feb. 15, 2020 /PRNewswire/ -- Informa Markets, the leading exhibition organiser inMalaysia, is supporting the government's efforts to share factual and up-to-date information on the COVID-19 situation inMalaysia with the business community

2020-02-15 14:40 2500

China Jo-Jo Drugstores Reports Third Quarter 2020 Financial Results

HANGZHOU, China, Feb. 14, 2020 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products and a provider of healthcare services inChina, today a...

2020-02-14 22:00 11056

WAT Medical's study finds that HeadaTerm TENS Therapy Provides a Fast Treatment for Acute Migraines in a Randomized Controlled Trial

VANCOUVER, Feb. 14, 2020 /PRNewswire/ -- WAT Medical is thrilled to announce the newest clinical study conducted for an anti-migraine device by the  HeadaTerm,for the treatment of migraines. The HeadaTerm TENS device was shown to decrease pain at an 11.8% better rate than many acute migraine medic...

2020-02-14 22:00 1473

Thailand's strong Covid-19 response builds confidence for MICE

BANGKOK, Feb. 14, 2020 /PRNewswire/ -- Actions taken by the Thai government and private agencies since the outbreak of 2019 Novel Coronavirus (Covid-19) have raised the confidence within the MICE industry as 24 international and regional conventions and exhibitions involving more than 40,000 part...

2020-02-14 17:40 4062
1 ... 267268269270271272273 ... 277